Wenshan Xu
- Co-authors
- Jin‐Jian LuYitao WangXiuping ChenNikita PopovGuosheng WuYuanye DangMin HuangMartin Eilers
- Topics
- Ubiquitin and proteasome pathways (7 papers)Peptidase Inhibition and Analysis (3 papers)Bioactive Compounds and Antitumor Agents (2 papers)
- Partner nations
- MacaoGermanyUnited Kingdom
In The Last Decade
Wenshan Xu
16 papers receiving 722 citations
Peers
Comparison fields: 5 of 84
- Molecular Biology 512
- Oncology 156
- Pharmacology 88
- Toxicology 71
- Epidemiology 71
Countries citing papers authored by Wenshan Xu
This map shows the geographic impact of Wenshan Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenshan Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenshan Xu more than expected).
Fields of papers citing papers by Wenshan Xu
This network shows the impact of papers produced by Wenshan Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenshan Xu. The network helps show where Wenshan Xu may publish in the future.
Co-authorship network of co-authors of Wenshan Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Wenshan Xu. A scholar is included among the top collaborators of Wenshan Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenshan Xu. Wenshan Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 51 | |
| 3 | 35 | |
| 4 | 73 | |
| 5 | 46 | |
| 6 | 8 | |
| 7 | 52 | |
| 8 | 78 | |
| 9 | 21 | |
| 10 | 16 | |
| 11 | 96 | |
| 12 | 158 | |
| 13 | 26 | |
| 14 | 1 | |
| 15 | 55 | |
| 16 | [Inspirations from natural products based drug research and development for Chinese medicine research--analysis of natural products recoded in TTD]. | 1 |
About Wenshan Xu
Wenshan Xu is a scholar working on Toxicology, Complementary and alternative medicine and Geriatrics and Gerontology, having authored 16 papers that have together received 726 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (7 papers), Peptidase Inhibition and Analysis (3 papers) and Bioactive Compounds and Antitumor Agents (2 papers). The work is most often cited by research in Toxicology (71 citations), Applied Microbiology and Biotechnology (20 citations) and Molecular Medicine (49 citations). Wenshan Xu has collaborated with scholars based in Macao, Germany and United Kingdom. Frequent co-authors include Jin‐Jian Lu, Yitao Wang, Xiuping Chen, Nikita Popov, Guosheng Wu, Yuanye Dang, Min Huang, Martin Eilers, Jiaolin Bao and Xiuping Chen. Their work appears in journals such as Nucleic Acids Research, Molecular Cell and Journal of Ethnopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.